Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 4427
If the Licensor does not elect to participate in co-promotion in one or more North American countries, the Licensee will solely commercialize products developed under the agreement.
The Licensee will have sole development and commercialization rights to the products and compounds developed under the agreement in selected countries in Asia, the Pacific, the Middle East and North Africa.
The Licensor will have sole development and commercialization rights to the products and compounds developed under the agreement in Europe and South America, and other regions, or countries outside North America and the Licensee sole territory.
Emixustat is a small molecule notable for its establishment of a new class of compounds known as visual cycle modulators. Formulated as the hydrochloride salt, emixustat hydrochloride, it is the first synthetic medicinal compound shown to affect retinal disease processes when taken by mouth.
IPSCIO Record ID: 7490
IPSCIO Record ID: 249885
AMD means Age-related macular degeneration.